SEATTLE, May 31, 2011 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert
Kirkman, M.D., President and Chief Executive Officer, will present at the Jefferies 2011 Global Healthcare Conference in New York on Monday, June 6, 2011, at 8:30
A live and archived webcast of Dr. Kirkman's presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...